Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Mycobacterium tuberculosis (Mtb) is an obligate aerobe that is capable of long-term persistence under conditions of low oxygen tension. Analysis of the Mtb genome predicts the existence of a branched aerobic respiratory chain terminating in a cytochrome bd system and a cytochrome aa 3 system. Both chains can be initiated with type II NADH:menaquinone oxidoreductase. We present a detailed biochemical characterization of the aerobic respiratory chains from Mtb and show that phenothiazine analogs specifically inhibit NADH:menaquinone oxidoreductase activity. The emergence of drug-resistant strains of Mtb has prompted a search for antimycobacterial agents. Several phenothiazines analogs are highly tuberculocidal in vitro , suppress Mtb growth in a mouse model of acute infection, and represent lead compounds that may give rise to a class of selective antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Weinstein et al. identified genes for two classes of NADH:menaquinone oxidoreductases in the genome of M. tuberculosis (12) (Table 1).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“NDH-2 has not been reported in mammalian mitochondria leading to the proposal that these enzymes may represent a potential drug target for the treatment of human pathogens (6, 12, 27, 30, 31) and intracellular parasites (32).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“The second class is NDH-2, a non-proton translocating type II NADH dehydrogenase that does not conserve energy and is present in two copies (Ndh and NdhA) in M. tuberculosis (12) (Table 1).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Several studies have suggested that ndh is essential for growth of M. tuberculosis (12, 26, 28, 29) (Table 1).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
Self-citationFerguson-Miller, S., & Babcock, G. T. (1996) · Chemical Reviews · doi:10.1021/cr950051s · Cited by 1,157
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Unden, G., & Bongaerts, J. (1997) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(97)00034-0 · Cited by 742
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Quinones as the Redox Signal for the Arc Two-Component System of Bacteria
Georgellis, D., Kwon, O., & Lin, E. C. C. (2001) · Science · doi:10.1126/science.1059361 · Cited by 465
Voskuil, M. I., Visconti, K. C., & Schoolnik, G. K. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.02.003 · Cited by 448
Dormancy ofMycobacterium tuberculosis and latency of disease
Wayne, L. G. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111491 · Cited by 387
Two Sensor Kinases Contribute to the Hypoxic Response of Mycobacterium tuberculosis
Roberts, D. M., Liao, R. P., Wisedchaisri, G., Hol, W. G. J., & Sherman, D. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401230200 · Cited by 262
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Characterization of the cydAB -Encoded Cytochrome bd Oxidase from Mycobacterium smegmatis
Kana, B. D., Weinstein, E. A., Avarbock, D., Dawes, S. S., Rubin, H., & Mizrahi, V. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.24.7076-7086.2001 · Cited by 153
Self-citationAmaral, L., Kristiansen, J. E., Viveiros, M., & Atouguia, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.505 · Cited by 143
Chlorpromazine: A Drug Potentially Useful for Treating Mycobacterial Infections
Crowle, A. J., Douvas, G. S., & May, M. H. (2009) · Chemotherapy · doi:10.1159/000239036 · Cited by 128
McAdam, R. A., Quan, S., Smith, D. A., Bardarov, S., Betts, J. C., Cook, F. C., Hooker, E. U., Lewis, A. P., Woollard, P., Everett, M. J., et al. (2002) · Microbiology · doi:10.1099/00221287-148-10-2975 · Cited by 128
Self-citationTuberculosis and Nontuberculous Mycobacterial Infections
(2017) · ASM Press eBooks · doi:10.1128/9781555819866 · Cited by 124
Calhoun, M. W., & Gennis, R. B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.10.3013-3019.1993 · Cited by 109
O'Toole, R., Smeulders, M. J., Blokpoel, M. C., Kay, E. J., Lougheed, K., & Williams, H. D. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.5.1543-1554.2003 · Cited by 102
Regulation of transcription at the ndh promoter of Escherichia coli by FNR and novel factors
Green, J., & Guest, J. R. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01032.x · Cited by 80
Amplification of the respiratory NADH dehydrogenase of Escherichia coli by gene cloning
Young, I. G., Jaworowski, A., & Poulis, M. I. (1978) · Gene · doi:10.1016/0378-1119(78)90012-4 · Cited by 77
10 The Analysis of Cytochromes
Jones, C. W., & Poole, R. K. (1985) · Methods in microbiology · doi:10.1016/s0580-9517(08)70479-3 · Cited by 76
THE ANTIBACTERIAL EFFECT OF SELECTED PHENOTHIAZINES AND THIOXANTHENES ON SLOW‐GROWING MYCOBACTERIA
Kristiansen, J. E., & Vergmann, B. (1986) · Acta Pathologica Microbiologica Scandinavica Section B Microbiology · doi:10.1111/j.1699-0463.1986.tb03073.x · Cited by 57
Sone, N., Nagata, K., Kojima, H., Tajima, J., Kodera, Y., Kanamaru, T., Noguchi, S., & Sakamoto, J. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00205-x · Cited by 55
Wackwitz, B., Bongaerts, J., Goodman, S. D., & Unden, G. (1999) · Molecular and General Genetics MGG · doi:10.1007/s004380051153 · Cited by 54
Studies on antituberculotic action of some phenothiazine derivatives in vitro.
Molnár, J., BELADI, I., & Földeş, I. (1977) · PubMed · Cited by 42
Antitubercular activity of trifluoperazine, a calmodulin antagonist
Ratnakar, P., & Murthy, P. S. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05442.x · Cited by 39
Antitubercular activity of trifluoperazine, a calmodulin antagonist
Ratnakar, P. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90366-v · Cited by 31
Gadre, D. V., Talwar, V., Gupta, H. C., & Murthy, R. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199805000-00006 · Cited by 25
In-vitro and intracellular antimycobacterial activity of trifluoperazine
REDDY, M. V., Nadadhur, G., & Gangadharam, P. R. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.1.196 · Cited by 20
Effect of trifluoperazine on in vitro ATP synthesis by Mycobacterium leprae
Katoch, V. M., Saxena, N., Shivannavar, C. T., Sharma, V. D., Katoch, K., Sharma, R., & Murthy, P. S. (1998) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1998.tb01115.x · Cited by 15
Research works printed but not linked: 3
- Ratnakar, P. & Murthy, P. S. (1992) FEMS Microbiol. Lett. 76, 73–76.1427006
- Molnar, J., Beladi, I. & Földes, I. (1977) Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A 239, 521–526.
- Kristiansen, J. E. & Vergmann, B. (1986) Acta Pathol. Microbiol. Scand. Sec. B. 94, 393–398.
Cited by
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Rao, S. P. S., Alonso, S., Rand, L., Dick, T., & Pethe, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711697105 · Cited by 517
Antituberculosis drugs: Ten years of research
Janin, Y. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.030 · Cited by 485
Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
Yano, T., Kassovska-Bratinova, S., Teh, J. S., Winkler, J., Sullivan, K., Isaacs, A., Schechter, N. M., & Rubin, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200501 · Cited by 346
Self-citation
Metadata
- Authors
- Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Rubin, Harvey
- ORCID
- Rubin, Harvey
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-03-14
- Volume
- 102
- Issue
- 12
- Pages
- 4548-4553
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC555520
- OpenAlex
- W1986111503
- Cited by
- 289
- References
- 30
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 7 · 2023: 15 · 2022: 13 · 2021: 13 · 2020: 11 · 2019: 19 · 2018: 19 · 2017: 26 · 2016: 9 · 2015: 15 · 2014: 26 · 2013: 8 · 2012: 15
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI043420, AI-43420)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- Mycobacterium tuberculosis, antitubercular agents, aerobic respiratory chain, electron transport inhibition, drug resistance, low oxygen tension
- MeSH terms
- Animals, Antitubercular Agents, Electron Transport, Enzyme Inhibitors, Escherichia coli, Female, Genes, Bacterial, Mice, Inbred BALB C, Mycobacterium tuberculosis, Oxygen Consumption, Phenothiazines, Quinone Reductases, Recombinant Proteins, Tuberculosis, Pulmonary, Electron Transport Complex III, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.